索托拉西布(AMG510)

CAS: 2296729-00-3 货号: S409151 分子式: C30H30F2N6O3 分子量: 560.59 PubChem CID: 137278711
有货
级别和纯度: 10mM in DMSO
储存条件
-80℃储存
运输条件
特低温运输
★
规格
库存
价格
数量
1ml
S409151-1ml
现货 Stock Image
¥1,225.90
请输入您要添加的产品数量

概述

索托拉西布(AMG-510) 是一种有效的,口服生物可利用的,选择性的 KRAS G12C 共价抑制剂。Sotorasib 将 KRAS G12C 锁定在非活跃的 GDP 约束状态。Sotorasib 是临床开发的第一个 KRAS G12C 抑制剂,能使 KRAS G12C 肿瘤消退。

Information

Sotorasib (AMG510) Sotorasib (AMG510) is a potent KRAS G12C covalent inhibitor with potential antineoplastic activity. This AMG510 is a chiral compound.
In vitro

AMG 510 inhibits SOS1-catalyzed nucleotide exchange of recombinant mutant KRAS (G12C/C118A) but had minimal effect on KRAS (C118A). AMG 510 also selectively impairs the viability of KRAS p.G12C mutant lines but does not affect cell lines with other KRAS mutations.

In vivo

In preclinical tumor models, AMG 510 rapidly and irreversibly binds to KRAS (G12C), providing durable suppression of the mitogen-activated protein kinase (MAPK) signaling pathway. Dosed orally (once daily) as a single agent, AMG 510 is capable of inducing tumor regression in mouse models of KRASG12C cancer.
Cell Data

cell lines:

Concentrations:

Incubation Time:

Powder Purity:≥98%

规格

规格或纯度
10mM in DMSO
英文名称
Sotorasib (AMG510)
生化机理
索托拉西布(AMG510)是一种具有潜在抗肿瘤活性的强效 KRAS G12C 共价抑制剂。
储存条件
-80℃储存
运输条件
特低温运输
名称和识别符
分子类型
小分子
Isomeric SMILES
C[C@H]1CN(CCN1C2=NC(=O)N(C3=NC(=C(C=C32)F)C4=C(C=CC=C4F)O)C5=C(C=CN=C5C(C)C)C)C(=O)C=C
PubChem CID
分子量
560.59

高级数据

关联靶点(人)
KRAS Tclin GTP酶KRas(GTPase KRas) (2 活性数据)
活性类型 活性值-log(M) 作用机制 期刊 参考文献(PubMed IDs)
质检证书(CoA,COO,BSE/TSE 和分析图谱)
C of A & Other Certificates(BSE/TSE, COO):
输入批号以搜索分析图谱:
技术文档和文章
中药分子RA-V—协同KRAS G12C抑制的潜力因子 引言:靶向KRAS G12C的瓶颈与突破口
KRAS抑制剂——不可成药靶点”?已是历史
KRAS Inhibitors — The "Undruggable Target"? A Thing of the Past
从哌啶到吡啶:2013–2023 FDA 小分子新药里“最常见含氮杂环”更替与选型导航(表1–4)
From Piperidine to Pyridine: The “Most Common N-Heterocycle” Shift in FDA Small-Molecule New Drugs (2013–2023) and a Selection Guide (Tables 1–4)
Traditional Chinese Medicine Molecule RA-V: A Potential Synergistic Factor in KRAS G12C Inhibition
MAPK/ERK 信号通路:RAS–RAF–MEK–ERK 级联调控、细胞功能输出与研究工具应用
MAPK/ERK Signaling Pathway: RAS–RAF–MEK–ERK Cascade Regulation, Cellular Functional Outputs, and Research Tool Applications
非小细胞肺癌的分子分型、驱动靶点与耐药机制
Molecular Classification, Oncogenic Drivers, and Resistance Mechanisms of Non-Small Cell Lung Cancer
此产品的引用文献
溶液计算器